Department of Medicine

Cardiovascular Medicine Faculty

Eileen Handberg, PhD, ARNP,BC Division of Cardiovascular Medicine Associate Professor of Medicine Director, Clinical Trials Program; Program Director, Florida CARES & CAP e-mail: handbem@medicine.ufl.edu

Training:

Academic Interests:

Dr. Handberg is the Principal Investigator for the NHLBI sponsored HF ACTION trial, and Co-Investigator of the NIH Women’s Ischemic Syndrome Evaluation Study.  Her research interests include exercise, heart failure and ischemic heart disease. She is the Director of the Clinical Trials Program, which supports the research mission for the faculty, fellow and staff by providing administrative (fiscal and regulatory) and coordinator support. She directs Florida CARES & CAP which is a practitioner competency program.  She is active in the American Heart Association and American College of Cardiology.  She serves as Chair of the Continuing Nurse Education committee for the ACC, and serves on several committees. She is the Program Liaison for the Vascular Biology Working Group (www.vbwg.org).

Clinical Interests:

Exercise and Lifestyle Interventions, Ischemic Heart Disease in Women, Heart Failure

Representative Publications:

• Pepine CJ, Kowey PR, Kupfer S, Kollock RE, Benetos A, Mancia G, Coca A. Cooper-DeHoff RM, Handberg E,Gaxiola E, Sleight P, Conti CR, Hewkin AC, Tavazzi L; INVEST Investigators. Predictors of adverse outcome among patients with hypertension and coronary artery disease. J Am Coll Cardiol 2006 Feb 7; 47(3):547-51.
• Pepine CJ, Kowey PR, Kupfer S, Kollock RE, Benetos A, Mancia G, Coca A. Cooper-DeHoff RM, Handberg E, Gaxiola E, Sleight P, Conti CR, Hewkin AC, Tavazzi L; INVEST Investigators. Predictors of adverse outcome among patients with hypertension and coronary artery disease. J Am Coll Cardiol 2006 Feb 7; 47(3):547-51.
• ShawShaw, LJ, Olson MB, Kip K, Kelsey SF, Johnson BD, Mark DB, Reis SE, Mankad S, Rogers WJ, Pohost GM, Arant CB, Wessel TR, Chaitman BR, Sopko G, Handberg E, Pepine CJ, Bairey Merz CN. The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 2006 Feb 7;47(3 Suppl):S36-43.
• Handberg E, Johnson BD, Arant CB, Wessel TR, Kerensky RA, von Mering G, Olson MB, Reis SE, Shaw L, Bairey Merz CN, Sharaf BL, Sopko G, Pepine CJ. Impaired coronary vascular reactivity and functional capacity in women: results from the NHLBI Women’s Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 2006 Feb 7;47(3 Suppl):S44-9.
• Ried DL, Tueth MJ, Handberg E, Nyanteh H. Validating a self-report measure of global subjective well-being to predict adverse clinical outcomes. Quality of Life Research 2006 (15) 675-686.
• Sears SF, Vazquez Sowell L, Kuhl EA, Handberg EM, Kron J, Aranda Jr, JM, Conti JB. Quality of Death: Implantable cardioverter defibrillators and proactive care. PACE 2006; 29:637-642.
  

Visit Pubmed for full list of publications